Pushpendra Kumar’s Post

@Machine Learning, Artificial Intelligence, Deep Learning, Computer Vision, Robotics, Python, Gen AI

The implementation of GenAI in life sciences comes with critical ethical considerations that we must address to ensure a future where technology and humanity advance hand in hand. From analyzing vast amounts of structured data to extracting meaningful insights, C5i is paving the way for more efficient and innovative solutions. We leverage GenAI to tackle a wide range of challenges, from accelerating drug discovery and improving patient diagnostics to optimizing clinical trials and personalizing treatment plans.   Discover how C5i is leveraging GenAI in life sciences and driving business impact with our latest article by Kamal Kasi, VP C5i. Read more: https://lnkd.in/dcyd-skn #C5iHumanAIImpact #TransformativeIntelligence #GenAI #Innovation #FutureTech #TrustworthyAI #BusinessImpact

What a year for biotech! 2024 has been a game changer, showcasing the rapid evolution of the industry — from breakthroughs in obesity treatments (hello, GLP-1s 👋 ), to AI making its way into almost every part of the R&D lifecycle. It's been a busy year for us, too. In 2024, we launched hundreds of new capabilities to help our customers stay ahead of the curve, including: ✨ Benchling Analysis, a no-code solution that can automate data insights ✨ AI-powered productivity tools ✨ Specialized capabilities for scientists working across discovery, in vivo, and development ✨ And much more... Get the product recap: https://lnkd.in/eGcsi2ym

Excited to represent OM1, Inc. at DIA 2024 in San Diego! Meet us at Booth: 2309 to explore Deep Clinical Real-World Data, AI & Predictive Medicine, and Real-World Evidence and Analytics. With OM1's Real-World Data Cloud of over 300M patients, unlock insights for your drug pipeline. Don't miss OM1 CEO, Rich Gliklich, MD, in the innovation theater, sharing his vision for how #AI and #RWD are transforming clinical research and redefining the approach to prospective studies and registries. This is a must-see for anyone involved in prospective studies or registries! Discover how OM1, Inc. utilizes #automation and #AI to enhance #data collection for #research and #regulatory purposes. Join us to: 💡 Uncover hidden insights in your patient journeys. ✅ AI predictive and precision patient discovery ✅ EMR & data ingestion NLP, #AI, processing, linking at scale ✅ Automated registries and network-based clinical studies ✅ Plan and execute studies, including site and #patientidentification ✅ Specialized data networks in immunology, cardiometabolic, neuroscience, and respiratory diseases ✅ #Realworlddata for compliant #regulatory submissions 📍Not attending DIA? Send us a message 📩 (info@om1.com) for more insights. Looking forward to connecting with you all at #DIA2024! #BioPharma #BioTech #LifeSciences #ClinicalResearch #RWE #PatientJourney #PersonalizedMedicine #PredictiveMedicine #Pharma #OutcomesResearch

Great to see our investee Clarius Mobile Health CEO, Ohad Arazi address the Build vs Buy Dilemma when it comes to AI in Healthcare, alongside Michael Wilson of DrugBank and Susan Roberts of Relay Therapeutics, thoughtfully moderated by Florencia Herra Vega. Some useful insights into the challenges and opportunities in leveraging AI.. #healthtechignite2024 #healthtechignite #genAI

💊 Explore the inefficiencies in drug development and the potential for AI to enhance the process with Dmitry Zaika, a data product manager at BioAge Labs. Watch his LabWeek Field Building talk on revolutionizing biotech, streamlining workflows, and accelerating scientific discovery. 👇

#ISSCR2024 was full of promise and innovation! ✨ There was a huge amount of research and clinical development on display, especially in the #iPSC space 🧫. We've distilled all of this down into a couple of trends and innovations worth following, here are our two overarching trends to watch: 1. Single Cell Technologies, Molecular Insights, and Predictive AI tools 2. Complex 3D models, and Best Practices on Drug Screening Platforms for Inclusive Therapeutic Developments Did you attend? What were your thoughts? #ISSCR24 #stemcellresearch #celltherapy #sciencemeetsai

Montai CEO Margo Georgiadis will be on stage for the inaugural #HumanX2025 conference in Las Vegas in March, focused on the biggest challenges and opportunities in AI today. Curious? Learn more here. https://lnkd.in/eXRfy6eb

𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹: 𝗛𝗼𝘄 𝗔𝗜 𝗶𝘀 𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲 AI is streamlining drug development, speeding up the process while reducing costs. 🚀 Tune in to a recent webinar from Sano Genetics, hosted by our very own COO, Charlotte Guzzo to explore this fascinating space with leading industry experts (Parker Moss, Margo Georgiadis and Guillermo Del Angel). Check it out here: 👇 https://lnkd.in/dcVkXtHt #ClinicalTrials #PrecisionMedicine

Decoding advancements in Precision Medicine in Genomics at CES 2025. 1--> Precision Medicine translates into Right Treatment to Right Patient at Right Time. With the amount of data generated, Medical and Healthcare professionals are thirty for Insights - so that AI can deliver outcome driven cure. 2--> With the advent of AI we are at the inflection point were Right Drug at Right Time can become a reality. 3--> High infiltration of Matching People Genomics to Healthcare Recommendations for personalized care. 4--> Time is shrinking between the healthcare system and Life Science Companies i.e. Drug Development and Diagnostic Development and this move will further accelerate due to the Flywheels (Large Datasets uncovering rare insights). This along with partnership with therapeutic companies can develop a right drug. #serviots #CES2025 #precisionmedicine #personalizedcare